Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5576696 | The American Journal of Medicine | 2017 | 15 Pages |
Abstract
The short-term incidence of thromboembolism and major bleeding after cardioversion on non-vitamin K antagonist oral anticoagulants was comparable to the incidence observed on dose-adjusted vitamin K antagonist therapy. Non-vitamin K antagonist oral anticoagulants are a reasonable alternative to vitamin K antagonists in patients undergoing cardioversion.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Giulia MD, PhD, Fabrizio MD, Raffaele MD, PhD,